Abdallah Hayar
Concepts (212)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Olfactory Bulb | 10 | 2009 | 14 | 1.940 |
Why?
| Neurons | 18 | 2020 | 460 | 1.810 |
Why?
| Action Potentials | 9 | 2015 | 132 | 1.270 |
Why?
| Patch-Clamp Techniques | 14 | 2018 | 124 | 0.890 |
Why?
| Rats, Sprague-Dawley | 21 | 2015 | 1597 | 0.750 |
Why?
| gamma-Aminobutyric Acid | 7 | 2015 | 65 | 0.750 |
Why?
| Synapses | 6 | 2010 | 87 | 0.730 |
Why?
| Drinking Behavior | 2 | 2013 | 6 | 0.720 |
Why?
| Synaptic Transmission | 6 | 2012 | 90 | 0.670 |
Why?
| Rats | 23 | 2020 | 3305 | 0.670 |
Why?
| Sleep, REM | 5 | 2012 | 44 | 0.600 |
Why?
| Glutamic Acid | 5 | 2010 | 107 | 0.560 |
Why?
| Periodicity | 3 | 2013 | 24 | 0.530 |
Why?
| Receptors, Metabotropic Glutamate | 4 | 2009 | 14 | 0.510 |
Why?
| Animals | 30 | 2021 | 13187 | 0.480 |
Why?
| Electrophysiology | 3 | 2010 | 78 | 0.440 |
Why?
| Olfactory Nerve | 4 | 2009 | 5 | 0.430 |
Why?
| Smell | 3 | 2007 | 11 | 0.370 |
Why?
| Receptors, GABA-B | 2 | 2007 | 11 | 0.370 |
Why?
| Neurobiology | 1 | 2010 | 4 | 0.360 |
Why?
| Gap Junctions | 1 | 2010 | 26 | 0.350 |
Why?
| Oocytes | 1 | 2010 | 74 | 0.340 |
Why?
| Neural Inhibition | 5 | 2010 | 26 | 0.330 |
Why?
| Brain | 4 | 2019 | 1328 | 0.330 |
Why?
| Wakefulness | 2 | 2008 | 52 | 0.330 |
Why?
| Neurotransmitter Agents | 1 | 2008 | 34 | 0.310 |
Why?
| Ganglia, Spinal | 1 | 2008 | 48 | 0.310 |
Why?
| Excitatory Amino Acid Agonists | 4 | 2012 | 20 | 0.290 |
Why?
| Calcium | 2 | 2009 | 396 | 0.290 |
Why?
| Sleep | 2 | 2007 | 184 | 0.290 |
Why?
| Benzhydryl Compounds | 1 | 2007 | 67 | 0.290 |
Why?
| Diagnostic Imaging | 1 | 2008 | 176 | 0.280 |
Why?
| Analog-Digital Conversion | 1 | 2005 | 3 | 0.270 |
Why?
| Excitatory Postsynaptic Potentials | 6 | 2011 | 30 | 0.270 |
Why?
| Membrane Potentials | 5 | 2010 | 117 | 0.270 |
Why?
| Glomerular Basement Membrane | 1 | 2005 | 10 | 0.260 |
Why?
| Male | 19 | 2021 | 25241 | 0.260 |
Why?
| Female | 20 | 2021 | 26472 | 0.250 |
Why?
| Central Nervous System Stimulants | 1 | 2007 | 213 | 0.250 |
Why?
| Electric Stimulation | 5 | 2012 | 118 | 0.240 |
Why?
| Theta Rhythm | 1 | 2004 | 10 | 0.230 |
Why?
| Purkinje Cells | 2 | 2015 | 17 | 0.230 |
Why?
| Central Nervous System Depressants | 2 | 2015 | 79 | 0.220 |
Why?
| Excitatory Amino Acid Antagonists | 4 | 2009 | 51 | 0.220 |
Why?
| Astrocytes | 2 | 2020 | 145 | 0.200 |
Why?
| Protein C | 1 | 2021 | 18 | 0.190 |
Why?
| Connexins | 3 | 2010 | 25 | 0.190 |
Why?
| Ethanol | 2 | 2015 | 340 | 0.180 |
Why?
| Intestine, Small | 1 | 2021 | 109 | 0.180 |
Why?
| Neural Stem Cells | 1 | 2020 | 25 | 0.180 |
Why?
| Cerebellum | 3 | 2015 | 135 | 0.180 |
Why?
| Locus Coeruleus | 2 | 2012 | 10 | 0.180 |
Why?
| Exosomes | 1 | 2020 | 49 | 0.170 |
Why?
| Reticular Formation | 3 | 2008 | 28 | 0.170 |
Why?
| Glycine | 3 | 2010 | 75 | 0.170 |
Why?
| Thiotepa | 1 | 2019 | 5 | 0.170 |
Why?
| Intralaminar Thalamic Nuclei | 2 | 2009 | 6 | 0.160 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2019 | 74 | 0.160 |
Why?
| Animals, Newborn | 5 | 2015 | 367 | 0.160 |
Why?
| Cell Membrane | 2 | 2010 | 248 | 0.160 |
Why?
| Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 61 | 0.150 |
Why?
| Skin | 1 | 2021 | 409 | 0.150 |
Why?
| Image Processing, Computer-Assisted | 2 | 2017 | 242 | 0.150 |
Why?
| GABA Agonists | 2 | 2007 | 15 | 0.150 |
Why?
| Cell Differentiation | 1 | 2020 | 651 | 0.150 |
Why?
| Models, Theoretical | 1 | 2018 | 175 | 0.150 |
Why?
| Mice, Transgenic | 1 | 2018 | 555 | 0.140 |
Why?
| GABA Antagonists | 2 | 2007 | 11 | 0.130 |
Why?
| Software | 1 | 2017 | 273 | 0.120 |
Why?
| Thalamus | 2 | 2012 | 36 | 0.120 |
Why?
| N-Methylaspartate | 2 | 2012 | 27 | 0.120 |
Why?
| Kainic Acid | 2 | 2012 | 29 | 0.120 |
Why?
| Cholinergic Agonists | 3 | 2009 | 10 | 0.120 |
Why?
| Carbachol | 3 | 2009 | 27 | 0.120 |
Why?
| Sucrose | 1 | 2013 | 26 | 0.110 |
Why?
| Drinking | 1 | 2013 | 38 | 0.110 |
Why?
| Tongue | 1 | 2013 | 39 | 0.110 |
Why?
| Dendrites | 2 | 2009 | 29 | 0.110 |
Why?
| Alcohol Drinking | 1 | 2013 | 224 | 0.100 |
Why?
| Pedunculopontine Tegmental Nucleus | 1 | 2011 | 24 | 0.100 |
Why?
| Olivary Nucleus | 1 | 2011 | 7 | 0.100 |
Why?
| Nerve Fibers | 1 | 2011 | 11 | 0.100 |
Why?
| Cells, Cultured | 2 | 2020 | 1573 | 0.090 |
Why?
| Neurogenesis | 1 | 2011 | 27 | 0.090 |
Why?
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2007 | 7 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 3 | 2009 | 1376 | 0.090 |
Why?
| Xenopus laevis | 1 | 2010 | 38 | 0.090 |
Why?
| Mice, Inbred C57BL | 3 | 2021 | 1816 | 0.090 |
Why?
| Brain Stem | 1 | 2010 | 57 | 0.090 |
Why?
| Genetic Vectors | 1 | 2010 | 125 | 0.090 |
Why?
| Receptors, Cholinergic | 1 | 2009 | 14 | 0.080 |
Why?
| Mice | 4 | 2021 | 5739 | 0.080 |
Why?
| Evoked Potentials | 2 | 2009 | 72 | 0.080 |
Why?
| Receptors, Adrenergic | 1 | 2009 | 14 | 0.080 |
Why?
| Transfection | 1 | 2010 | 354 | 0.080 |
Why?
| Ion Channels | 1 | 2009 | 72 | 0.080 |
Why?
| Tetraethylammonium | 1 | 2008 | 2 | 0.080 |
Why?
| Norepinephrine | 1 | 2009 | 107 | 0.080 |
Why?
| Sodium Channel Blockers | 2 | 2009 | 13 | 0.080 |
Why?
| Cadmium | 1 | 2008 | 22 | 0.080 |
Why?
| Potassium Channel Blockers | 1 | 2008 | 16 | 0.080 |
Why?
| Pons | 1 | 2008 | 33 | 0.080 |
Why?
| Synaptic Membranes | 1 | 2007 | 2 | 0.080 |
Why?
| Neuropil | 1 | 2007 | 2 | 0.080 |
Why?
| Chromosome Pairing | 1 | 2007 | 1 | 0.080 |
Why?
| Baclofen | 1 | 2007 | 9 | 0.080 |
Why?
| Presynaptic Terminals | 1 | 2007 | 15 | 0.080 |
Why?
| Evoked Potentials, Auditory, Brain Stem | 1 | 2007 | 27 | 0.080 |
Why?
| Interneurons | 1 | 2007 | 31 | 0.080 |
Why?
| Isonicotinic Acids | 1 | 2007 | 1 | 0.070 |
Why?
| Pyridazines | 1 | 2007 | 10 | 0.070 |
Why?
| Nerve Net | 1 | 2008 | 69 | 0.070 |
Why?
| Arousal | 1 | 2007 | 98 | 0.070 |
Why?
| Valine | 1 | 2007 | 58 | 0.070 |
Why?
| Cerebral Cortex | 1 | 2008 | 200 | 0.070 |
Why?
| Drug Interactions | 1 | 2007 | 206 | 0.070 |
Why?
| GABA-B Receptor Antagonists | 1 | 2006 | 4 | 0.070 |
Why?
| Tacrine | 1 | 2006 | 4 | 0.070 |
Why?
| Xanthenes | 1 | 2006 | 7 | 0.070 |
Why?
| Receptors, Dopamine D2 | 1 | 2006 | 16 | 0.070 |
Why?
| Benzoates | 1 | 2006 | 22 | 0.070 |
Why?
| Neurons, Afferent | 1 | 2006 | 30 | 0.070 |
Why?
| Aspartic Acid | 1 | 2006 | 49 | 0.070 |
Why?
| Pyramidal Cells | 1 | 2005 | 19 | 0.070 |
Why?
| Costs and Cost Analysis | 1 | 2005 | 95 | 0.060 |
Why?
| Neuronal Plasticity | 1 | 2006 | 58 | 0.060 |
Why?
| Chlorides | 1 | 2005 | 50 | 0.060 |
Why?
| Axons | 1 | 2005 | 45 | 0.060 |
Why?
| Culture Media | 1 | 2005 | 94 | 0.060 |
Why?
| Inhibitory Postsynaptic Potentials | 3 | 2010 | 9 | 0.060 |
Why?
| Behavior, Animal | 1 | 2005 | 181 | 0.060 |
Why?
| Calcium Signaling | 1 | 2004 | 56 | 0.060 |
Why?
| Amino Acids | 1 | 2006 | 360 | 0.060 |
Why?
| Calcium Channel Blockers | 1 | 2004 | 62 | 0.060 |
Why?
| Research Design | 1 | 2005 | 344 | 0.060 |
Why?
| Medulla Oblongata | 1 | 2002 | 21 | 0.050 |
Why?
| Receptors, Opioid | 1 | 2002 | 18 | 0.050 |
Why?
| Immunoblotting | 1 | 2021 | 118 | 0.050 |
Why?
| Infant, Newborn | 1 | 2008 | 2772 | 0.050 |
Why?
| Elastin | 1 | 2020 | 23 | 0.050 |
Why?
| Primary Cell Culture | 1 | 2020 | 61 | 0.050 |
Why?
| STAT3 Transcription Factor | 1 | 2020 | 81 | 0.040 |
Why?
| Coculture Techniques | 1 | 2020 | 146 | 0.040 |
Why?
| Receptors, Muscarinic | 2 | 2010 | 19 | 0.040 |
Why?
| Genotype | 1 | 2021 | 537 | 0.040 |
Why?
| Pregnancy | 3 | 2015 | 2607 | 0.040 |
Why?
| Heart Rate | 1 | 2021 | 293 | 0.040 |
Why?
| Infant | 1 | 2008 | 3567 | 0.040 |
Why?
| Glioma | 1 | 2020 | 79 | 0.040 |
Why?
| Child, Preschool | 1 | 2008 | 3871 | 0.040 |
Why?
| Injections, Intraperitoneal | 1 | 2019 | 54 | 0.040 |
Why?
| Maze Learning | 1 | 2019 | 35 | 0.040 |
Why?
| Interleukin-6 | 1 | 2020 | 264 | 0.040 |
Why?
| Movement | 1 | 2019 | 82 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 2020 | 193 | 0.040 |
Why?
| Heart | 1 | 2021 | 326 | 0.040 |
Why?
| Tissue Culture Techniques | 1 | 2018 | 40 | 0.040 |
Why?
| Luminescent Proteins | 1 | 2018 | 53 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2021 | 973 | 0.040 |
Why?
| Radionuclide Imaging | 1 | 2017 | 116 | 0.040 |
Why?
| Single-Cell Analysis | 1 | 2017 | 57 | 0.040 |
Why?
| Adolescent | 1 | 2008 | 6356 | 0.030 |
Why?
| Cognition | 1 | 2019 | 338 | 0.030 |
Why?
| Cell Proliferation | 1 | 2020 | 1007 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 475 | 0.030 |
Why?
| Cytokines | 1 | 2019 | 612 | 0.030 |
Why?
| Child | 1 | 2008 | 6847 | 0.030 |
Why?
| Biophysical Phenomena | 1 | 2015 | 19 | 0.030 |
Why?
| Humans | 5 | 2020 | 49974 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2020 | 976 | 0.030 |
Why?
| Cell Count | 1 | 2015 | 147 | 0.030 |
Why?
| Signal Transduction | 1 | 2002 | 1618 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 138 | 0.030 |
Why?
| Time Factors | 2 | 2010 | 2903 | 0.030 |
Why?
| Adult | 1 | 2008 | 13236 | 0.030 |
Why?
| Age Factors | 1 | 2015 | 1087 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 2012 | 99 | 0.020 |
Why?
| Receptors, Kainic Acid | 1 | 2011 | 8 | 0.020 |
Why?
| Receptors, Glutamate | 1 | 2011 | 10 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2011 | 108 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2011 | 88 | 0.020 |
Why?
| Neuronal Tract-Tracers | 1 | 2010 | 1 | 0.020 |
Why?
| Models, Animal | 1 | 2011 | 233 | 0.020 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 127 | 0.020 |
Why?
| Flufenamic Acid | 1 | 2009 | 1 | 0.020 |
Why?
| Catechols | 1 | 2009 | 7 | 0.020 |
Why?
| Intracellular Space | 1 | 2009 | 25 | 0.020 |
Why?
| Neural Pathways | 1 | 2010 | 99 | 0.020 |
Why?
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2009 | 1 | 0.020 |
Why?
| Receptors, Nicotinic | 1 | 2010 | 76 | 0.020 |
Why?
| Acetylcholine | 1 | 2009 | 54 | 0.020 |
Why?
| Potassium Channels | 1 | 2009 | 31 | 0.020 |
Why?
| Prazepam | 1 | 2009 | 1 | 0.020 |
Why?
| Adrenergic Antagonists | 1 | 2009 | 1 | 0.020 |
Why?
| Sodium | 1 | 2009 | 92 | 0.020 |
Why?
| Tetrodotoxin | 1 | 2009 | 10 | 0.020 |
Why?
| Electric Impedance | 1 | 2009 | 41 | 0.020 |
Why?
| Adrenergic Agonists | 1 | 2009 | 8 | 0.020 |
Why?
| GABA Modulators | 1 | 2009 | 9 | 0.020 |
Why?
| Inhibitory Concentration 50 | 1 | 2009 | 76 | 0.020 |
Why?
| Imidazoles | 1 | 2009 | 119 | 0.020 |
Why?
| Analysis of Variance | 1 | 2009 | 562 | 0.020 |
Why?
| Methoxyhydroxyphenylglycol | 1 | 2007 | 6 | 0.020 |
Why?
| Isoquinolines | 1 | 2007 | 25 | 0.020 |
Why?
| Biotin | 1 | 2007 | 45 | 0.020 |
Why?
| Fluorescent Dyes | 1 | 2007 | 102 | 0.020 |
Why?
| RNA, Messenger | 1 | 2007 | 1105 | 0.010 |
Why?
| Enkephalins | 1 | 2002 | 6 | 0.010 |
Why?
| Vasomotor System | 1 | 2002 | 4 | 0.010 |
Why?
| Protein Precursors | 1 | 2002 | 43 | 0.010 |
Why?
| Narcotics | 1 | 2002 | 111 | 0.010 |
Why?
| Narcotic Antagonists | 1 | 2002 | 135 | 0.010 |
Why?
|
|
Hayar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|